Saturday, June 25 2022

LOS ANGELES–(BUSINESS WIRE)–Schall law firma national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enochian Biosciences, Inc. (“Enochian Biosciences” or “the Company”) (NASDAQ: ENOB) for violating securities laws.

The investigation aims to determine whether the Company has made false and/or misleading statements and/or has failed to disclose relevant information to investors. The DOJ announced the arrest of Enochian Biosciences co-founder and inventor Serhat Gumrukçu on May 25, 2022, during trading hours. Gumrukçu is facing murder-for-hire charges. Based on this news, shares of Enochian Biosciences fell 37% on the same day.

If you are a shareholder who has suffered a loss, Click here to participate.

We also encourage you to contact Brian Schall of Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us via the firm’s website at www.schallfirm.comor by e-mail to [email protected]

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to do nothing, you can remain an absent member of the group.

Schall Law Firm represents investors worldwide and specializes in securities class action and shareholder rights litigation.

This press release may be considered attorney advertising in certain jurisdictions under applicable law and ethical requirements.


DigiTech's South African "App Store" uses R925 website template


Kirby McInerney LLP continues investigation of shareholder claims on behalf of GoodRx Holdings, Inc. (GDRX) investors

Check Also